AdvancedAdvT Limited
05 October 2026
This announcement contains inside information
for the purposes of UK Market Abuse Regulation.
5 October 2026
AdvancedAdvT Limited
Purchase of Own Shares
AdvancedAdvT Limited (AIM: ADVT, “AdvT”, the “Group”, the “Company”), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces that further to the confirmation of its intention to renew its share buyback programme, as set out in its announcement on 16 September 2026, in the period from 28 September 2026 up to and including 2 October 2026, it purchased a further 115,000 of its ordinary shares of no par value in the capital of the Company (“Ordinary Shares”). The Ordinary Shares purchased will be held in treasury.
Following this purchase, the cumulative number of Ordinary Shares purchased under the Company’s buyback programmes since 4 March 2026 is 6,326,453.
Aggregated information
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid per Ordinary Share |
Lowest price paid per Ordinary Share |
Volume Weighted price paid per Ordinary Share |
|
29 September 2026 |
5,000 |
180.000p |
180.000p |
180.000p |
|
30 September 2026 |
10,000 |
179.718p |
179.718p |
179.718p |
|
1 October 2026 |
100,000 |
179.103p |
179.103p |
179.103p |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation)(which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:
|
Date of purchase |
Number of Ordinary Shares purchased |
Transaction price |
Time of transaction |
Trading venue |
|
29 September 2026 |
5,000 |
180.000p |
16:32 |
AIMX |
|
30 September 2026 |
10,000 |
179.718p |
16:15 |
AIMX |
|
1 October 2026 |
50,000 |
179.103p |
11:08 |
AIMX |
|
1 October 2026 |
50,000 |
179.103p |
11:09 |
AIMX |
Total voting rights
Following the purchase, the Company's total issued share capital will consist of 137,125,806 Ordinary Shares each carrying one voting right, of which 6,326,453 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 130,799,353. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The person responsible for arranging the release of this Announcement
on behalf of the Company is Gavin Hugill, Chief Financial Officer.
Enquiries:
|
AdvancedAdvT Limited |
|
|
Vin Murria, Chairperson Gavin Hugill, Chief Financial Officer |
|
|
|
|
|
Singer Capital Markets (Nominated Adviser and Broker) |
Tel: 020 7496 3000 |
|
James Moat / James Fischer |
|
|
|
|
|
KK Advisory (Investor Relations) |
Tel:020 7039 1901 |
|
Kam Bansil |
|
Note to Editors
AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.
AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in those sectors where long term digitisation trends are set to transform the workplace for professionals.
AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.